申请人:Peloton Therapeutics, Inc.
公开号:US20200115404A1
公开(公告)日:2020-04-16
Compounds that modulate CD73 activity, pharmaceutical compositions containing these compounds, and methods of using these compounds for treating diseases associated with CD73 activity are described herein.